Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Transthyretin amyloid neuropathy has earlier neural involvement but better prognosis than primary amyloid counterpart: an answer to the paradox?

Annals of neurology - 1 Sept 2016

Loavenbruck Adam J, Singer Wolfgang, Mauermann Michelle L, Sandroni Paola, B Dyck P James, Gertz Morie, Klein Christopher J, Low Phillip A

Abstract excerpt

OBJECTIVE: To systematically compare transthyretin with primary amyloid neuropathy to define their natural history and the underlying mechanisms for differences in phenotype and natural history. METHODS: All patients with defined amyloid subtype and peripheral neuropathy who completed autonomic testing and electromyography at Mayo Clinic Rochester between 1993 and 2013 were included. Medical records were reviewed...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Amyloid

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Amyloid Neuropathies

Share to Mutation

Share to Phenotype

Share to Prealbumin

Share to Prognosis

Source

Open in PubMed Open full text

Identifiers

PMID: 27422051
DOI: 10.1002/ana.24725
PMCID: PMC5016242

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Transthyretin amyloid neuropathy has earlier neural involvement but better prognosis than primary amyloid counterpart: an answer to the paradox?PMID 27422051Read ↗

Cardiovascular autonomic failure in hereditary transthyretin amyloidosis and TTR carriers is an early and progressive disease markerSemantic proximity Read ↗

Hereditary transthyretin amyloidosis: baseline characteristics of patients in the NEURO-TTR trial.Semantic proximity Read ↗

Guideline of transthyretin-related hereditary amyloidosis for cliniciansSemantic proximity Read ↗

Neuropathy Associated with Systemic Amyloidosis.Semantic proximity Read ↗

Hereditary transthyretin amyloidosis: a comprehensive review with a focus on peripheral neuropathySemantic proximity Read ↗

Clinical phenotypes and genetic features of hereditary transthyretin amyloidosis patients in China.Semantic proximity Read ↗

Transthyretin amyloidosis: an under-recognized neuropathy and cardiomyopathySemantic proximity Read ↗

Canadian Guidelines for Hereditary Transthyretin Amyloidosis Polyneuropathy ManagementSemantic proximity Read ↗

The neuropathy in hereditary transthyretin amyloidosis: A narrative review.Semantic proximity Read ↗

Hereditary transthyretin amyloidosis overview.Semantic proximity Read ↗

Detailed clinical, physiological and pathological phenotyping can impact access to disease-modifying treatments in ATTR carriers.Semantic proximity Read ↗

Autonomic involvement in hereditary transthyretin amyloidosis (hATTR amyloidosis)Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.